Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - India

India

In the year 2024, it is projected that the revenue in the Treatment of Musculoskeletal Diseases market in India will reach a staggering US$4.68bn.
This market segment is expected to demonstrate a steady growth rate of 7.05% annually between the years 2024 and 2029.
This growth is projected to result in a market volume of US$6.58bn by the year 2029.
When compared to other countries globally, it is noteworthy that in the United States will generate the highest revenue in this market segment, with an estimated value of US$60,790.00m in the year 2024.
India's treatment of musculoskeletal diseases is witnessing a surge in alternative therapies such as Ayurveda and yoga.

Key regions: United States, United Kingdom, Europe, Brazil, Germany

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.